Association of human herpesvirus 6 (HHV-6) in hematological malignancies and vertical transmission of HHV-6 genome
人类疱疹病毒 6 (HHV-6) 与血液恶性肿瘤的关联及 HHV-6 基因组的垂直传播
基本信息
- 批准号:11671002
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. Over the past 15 years three new human hepesviruses (HHV-6, HHV-7 and HHV-8) have been recognized and implicated as eliological agents of several human diseases. HHV-6 has been cited as a possible cause or as a modulating element of certain human lymphoproliferative disorders. We found two cases of lymphoma and ALL carrying chromosomally integrated HHV-6 genomes. To assess the possibility of chromosomal transmission of HHV-6 DNA, we looked for the viral genome in their families. In both cases, the HHV-6 genomes were detected in their offspring at the identical sites of viral integration of the patients. We propose a novel latent form for HHV-6, in which integrated HHV-6 genome can be chromosomally inherited.2.(1) Despite the genomic homology, and serological cross-reactivity between HHV-6 and HHV-7, evidence for the association of HHV-7 with lymphoproliferative disorders has been scarce. We searched for the HHV-7 genome in patients with lymphocytic leukemia. Sixty-one patients were enrolled : 33 adult ALL ; 15 childhood ALL ; and 13 CLL. HHV-7 genome was not found in any of our samples, suggesting that HHV-7 is unlikely to play a pathogenetic role in lymphocytic leukemia.(2) We evaluated the presence of four human herpesviruses (EBV, HHV-6, HHV-7 and HHV-8) in the specimens from 14 patients with primary ocular MALT lymphoma. EBV DNA were detected in 4 samples by PCR, and 4 cases were positive for HHV-6DNA. Neither HHV-7 nor HHV-8DNA could by detected. These findings suggested the possible involvement of EBV and HHV-6 in the pathogenesis of a subset of low-grade primary ocular lymphomas.(3) HHV-6 genome was detected in the brain lesions of progressive multifocal leukoencephalopathy (PML) developing in a lymphoma patient. HHV-6 is known to be reactivated during immunosuppression and can cause several fatal complications. We propose an association of HHV-6 with the pathogenesis of PML in immunocompromised hosts.
1.在过去的15年里,三种新的人类肝炎病毒(HHV-6、HHV-7和HHV-8)被认为是几种人类疾病的病原体。HHV-6被认为是某些人类淋巴增生性疾病的可能原因或调节因素。我们发现了两例淋巴瘤,均携带染色体整合的HHV-6基因组。为了评估HHV-6DNA通过染色体传播的可能性,我们寻找了他们家族中的病毒基因组。在这两个病例中,在他们的后代中,在患者病毒整合的相同位置检测到HHV-6基因组。我们提出了一种新的HHV-6潜伏形式,其中整合的HHV-6基因组可以在染色体上遗传。2。(1)尽管HHV-6和HHV-7之间存在基因组同源性和血清学交叉反应,但HHV-7与淋巴增殖性疾病相关的证据一直很少。我们在淋巴细胞白血病患者中搜索了HHV-7基因组。入选患者61例,成人ALL 33例,儿童ALL 15例,CLL 13例。在所有样本中均未发现HHV-7基因组,提示HHV-7在淋巴细胞性白血病中可能起致病作用。(2)我们检测了14例原发眼MALT淋巴瘤患者标本中四种人类疱疹病毒(EBV、HHV-6、HHV-7和HHV-8)。4例标本经聚合酶链式反应检测出EB病毒DNA,其中4例HHV-6DNA阳性。HHV-7和HHV-8DNA均未检出。这些发现提示EBV和HHV-6可能参与了一组低度恶性原发眼淋巴瘤的发病机制。(3)在1例淋巴瘤患者发生的进行性多灶性白质脑病(PML)的脑部病变中检测到HHV-6基因组。众所周知,HHV-6在免疫抑制期间会重新激活,可能会导致几种致命的并发症。我们建议HHV-6与免疫受损宿主中PML的发病机制有关。
项目成果
期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A.Hayakawa: "Genomic organization, tissue expression, and cellular localization of AF3p21, a fusion partner of MLL in therapy-related leukemia"Genes Chrom.Cancer. 30. 364-374 (2001)
A.Hayakawa:“AF3p21 的基因组组织、组织表达和细胞定位,AF3p21 是治疗相关白血病中 MLL 的融合伴侣”Genes Chrom.Cancer。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masanori Daibata: "Presence of human herpesvirus 6 DNA in cord blood cells."J Infect Dis. 179. 1046-1047 (1999)
Masanori Daibata:“脐带血细胞中存在人类疱疹病毒 6 DNA。”J Infect Dis。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
大畑雅典: "リンパ指向性ウイルスと造血器腫瘍"血液・腫瘍科. 41(2). 181-188 (2000)
Masanori Ohata:“嗜淋巴病毒和造血肿瘤”,血液学和肿瘤学 41(2) (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masanori Daibata: "Human herpesviruses in primary ocular lymphoma"Leukemia and Lymphoma. 37. 361-365 (2000)
Masanori Daibata:“原发性眼淋巴瘤中的人类疱疹病毒”白血病和淋巴瘤。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Daibata: "Presence of human herpesvirus 6 DNA in somatic cells."Blood. 95. 1108-1109 (2000)
M.Daibata:“体细胞中存在人类疱疹病毒 6 DNA。”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAIBATA Masanori其他文献
DAIBATA Masanori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAIBATA Masanori', 18)}}的其他基金
Oncogenesis of the infection- and chronic inflammatory-associated lymphomas and development of novel therapeutic strategy
感染和慢性炎症相关淋巴瘤的肿瘤发生和新治疗策略的开发
- 批准号:
17K09927 - 财政年份:2017
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of molecular mechanism of hematological malignancies associated with persistent viral infection
阐明与持续病毒感染相关的血液恶性肿瘤的分子机制
- 批准号:
26461423 - 财政年份:2014
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathogenesis of hematological malignancies caused by viral infection
病毒感染引起的血液系统恶性肿瘤的发病机制
- 批准号:
23591391 - 财政年份:2011
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of a novel methylated gene as a prognostic factor in hematological malignancies and its clinical application.
一种新型甲基化基因作为血液恶性肿瘤预后因素的鉴定及其临床应用。
- 批准号:
20591133 - 财政年份:2008
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the methylated genes in hematological malignancies
血液系统恶性肿瘤甲基化基因分析
- 批准号:
18591070 - 财政年份:2006
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inleetin and pathogenetic role of lymphotropic viruses in hematological malignancies.
嗜淋巴病毒在血液恶性肿瘤中的摄入和致病作用。
- 批准号:
14570986 - 财政年份:2002
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Human herpesvirus 6 and chromosomal integration
人类疱疹病毒6型和染色体整合
- 批准号:
468828 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Operating Grants
The clinical impact of inherited chromosomally-integrated human herpesvirus 6 (iciHHV-6): a comprehensive analysis using UK Biobank
遗传性染色体整合型人类疱疹病毒 6 (iciHHV-6) 的临床影响:使用英国生物银行的综合分析
- 批准号:
MR/T030941/1 - 财政年份:2020
- 资助金额:
$ 1.98万 - 项目类别:
Research Grant
Structure analysis of human herpesvirus 6 glycoprotein complex which is essential for the receptor binding
受体结合所必需的人疱疹病毒 6 糖蛋白复合物的结构分析
- 批准号:
19K06512 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of chromosomally integrated Human Herpesvirus 6 as a risk factor for Alzheimer's disease
染色体整合人类疱疹病毒 6 作为阿尔茨海默病危险因素的研究
- 批准号:
9904309 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Elucidation of the relationship between reproductive failure and human herpesvirus 6 and 7
阐明生殖障碍与人类疱疹病毒6型和7型之间的关系
- 批准号:
18K16799 - 财政年份:2018
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Human herpesvirus 6 and chromosomal integration
人类疱疹病毒6型和染色体整合
- 批准号:
370394 - 财政年份:2017
- 资助金额:
$ 1.98万 - 项目类别:
Operating Grants
Structure based analysis of human herpesvirus 6 transactivator IE2
人疱疹病毒 6 反式激活子 IE2 的结构分析
- 批准号:
17K15075 - 财政年份:2017
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Increased risk of cardiovascular disease in women with inherited chromosomally-integrated human herpesvirus 6
携带遗传性染色体整合型人类疱疹病毒 6 的女性患心血管疾病的风险增加
- 批准号:
339922 - 财政年份:2015
- 资助金额:
$ 1.98万 - 项目类别:
Operating Grants
Analysis of the role for human herpesvirus 6 gM/gN entry
人类疱疹病毒 6 gM/gN 进入的作用分析
- 批准号:
15K19112 - 财政年份:2015
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Human Herpesvirus 6 in Lower Respiratory Tract Disease and Chromosomal Integration after Hematopoietic Cell Transplantation
人类疱疹病毒6型下呼吸道疾病及造血细胞移植后染色体整合
- 批准号:
8948844 - 财政年份:2015
- 资助金额:
$ 1.98万 - 项目类别: